Article
Structural characterization of MAM01 and other cost-effective engineered monoclonal antibodies for malaria prevention
2025-08-27
Abstract excerpt
Long-lasting and effective vaccines or monoclonal antibodies (mAbs) for malaria prevention are highly beneficial for people of all ages living in malaria-endemic regions. Recently, two highly protective human mAbs AB000224 (IGHV3-49/IGLV1-40) and AB007088 (IGHV3-33/IGKV1-5), which are encoded by different germline genes, were re-engineered and renamed as MAM01 and MS-1805, respectively, to improve their half-life,...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 22e39199-5526-530f-933f-0996fec9b763
- DOI
- 10.1101/2025.08.24.672003
